Alarming tropical steroid misuse on face: A descriptive study by Dr. Rajkumar Kothiwala et al.
International Multispecialty Journal of Health (IMJH)                           ISSN: [2395-6291]                            [Vol-3, Issue-7, July- 2017] 
Page | 210  
Alarming tropical steroid misuse on face: A descriptive study 
Dr. Rajkumar Kothiwala
1
, Dr. Deepak S. Bohra
2§
, Dr. Rakesh Kumar
3
,  
Dr. Leela Ram Rawat
4
, Dr. Ashok Maherda
5
, Dr. Lokesh Chawal
6
, Dr. Chetan Sharma
7§ 
1
Associate Professor, Department of Skin & VD, JLN medical college Ajmer 
2,3,4,7
Junior Resident, Department of Skin & VD, JLN medical college Ajmer 
5
Senior Professor, Department of Skin & VD, JLN medical college Ajmer 
6
Assistant Professor, Department of Skin & VD, JLN medical college Ajmer 
§
Corresponding author's 
Abstract— Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit. The clinical 
lesions are non-inflammatory open and closed comedones and or papules, pustules and nodules of 
varying degree of inflammation and depth. A lot of steroid, cosmetic and Ayurvedic products containing 
unlabeled depigmenting agent and steroids are available readily over the counter sale. The side effects 
of these products are not documented and can lead to adverse effects of continuous usage. This study 
was aimed to find out various offending depigmenting agents (topical unlabeled steroid containing 
cosmetics) for treatment of Acne and its side effects with type of offering persons. This study was 
conducted on 1110 OPD patient of which 1000 (90.10%) patients are using steroid and unlabeled 
steroid containing cosmetics and only 110 (9.90%) patient not using any topical application. Mostly 
affected common age group was 11-20 years (58%) with slight female preponderance (M:F 0.96). 
Urban patients were more affected than rural (74% v/s 26%). Unmarrieds (76%) were more affected 
than married (24%). Friends appeared as chief culprit or suggestions given to them (39%) followed by 
family member(13.5%), self-application (12%) influenced by advertisements, chemist(11.5%), general 
practitioner (9.5%), neighbor (4.5%), compounder(1.5%), parlor(2%) and only 2% by dermatologist. 
Betamethasone (32.5%) was major offending agent followed by Clobetasol (25%), unlabeled steroid 
containing cosmetics (12.5%), Aloe Vera gel (7.5%). Monomorphic acne was main side effect diagnosed 
in 79% of patients followed by pustular acne (8%), nodular acne (4%), rosacea (4%), nodulocystic acne 
(3%) and perioral dermatitis (2%). Study concluded that misuse of topical steroids and unlabeled 
steroid containing cosmetics causing various side effects. It is unethical to sale and use without the 
prescription of an authorised person. So these depigmenting agents should be banned to sell without 
authorization and without the prescription of an authorised person. 
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I. INTRODUCTION 
Acne vulgaris is one of the most common skin diseases worldwide, affecting all ethnicities and races. 
The highest prevalence of acne occurs in adolescence where it may be diagnosed in 80% of all 
teenagers. The age of onset has changed over time, paralleling the earlier onset of puberty reported in 
recent years. Acne commonly has a prolonged course, with acute or insidious relapse or recurrence over 
time. 
Clinical presentation includes non-inflammatory and or inflammatory lesions. Topical steroids were 
introduced in 1951, when Sulzberger and Witten first used topical hydrocortisone.
1
 The anti-
inflammatory and anti-proliferative actions of topical steroids result not only in their therapeutic effect 
but also in their side effects. In this way steroids act as a double-edged sword, which makes it important 
to use it with the utmost caution. Topical steroids increase the proliferation of Propionibacterium acnes, 
and Demodex folliculorum, leading to an acne rosacea-like condition. The pathogenesis of topical 
steroid-induced acne has been proposed to be due to the degradation of the follicular epithelium, 
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resulting in the extrusion of the follicular content.
1 
Topical steroids hold the pride of place in every 
dermatologist's armory. However, the drug has been misused to varying extents by the pharmaceuticals 
and pharmacies, by the prescribers (who are not always dermatologists or doctors) and by the users. All 
this misuse results in severe cutaneous damage characterized by erythema, monomorphic acne, steroid 
atrophy, steroid rosacea, telangiectasia, perioral dermatitis, striae, and severe addiction to the  topical 
steroids. The face is the most common and most severely affected site of such misuse and steroid 
dependence.  
So this study was conducted with the aim to find out various offending depigmenting agents (topical 
unlabeled steroid containing cosmetics) for treatment of Acne and its side effects with type of offering 
persons. 
II. METHODOLOGY 
This hospital based descriptive type of observational study was carried out in the department of 
Dermatology, Venereology and Leprology, JLN Medical College, Ajmer (Rajasthan) during 1 June 
2016 to 31 may 2017 i.e. in one year.  
This study included 1000 consecutive patients of age between 11-40 years, having acne and who had 
given a written informed consent. Each patient was evaluated for acne in detail, including history 
regarding duration, qualification, name of steroid cream, culprit and offending de-pigmenting agents in 
unlabeled steroid containing cosmetics.  
Results were presented in percentage and proportions.  
III. RESULT 
Out of 1110 patients 1000 (90.10%) were using some creams which were having acne. Betamethasone 
was major offending agent (32.5%) followed by Clobetasol(25%), Fair N Lovely (12.5%), Aloe Vera 
Gel (7.5%) etc. (Table 1)  
Table 1 
Type of De-pigmenting Agents used by Study population (N=1000) 
S. No. Type of De-pigmenting Agents No. of Patient %  of Patient 
1 Cosmetic Aloe Vera 75 7.5 
2 Cosmetic Oil 5 0.5 
3 Betamethasone 325 32.5 
4 Boric Acid Containing Cream 5 0.5 
5 Clobetasol 250 25 
6 Dream Cream 5 0.5 
7 Facial Products 5 0.5 
8 Fair & Lovely 125 12.5 
9 Foundation 5 0.5 
10 Garnier Cream 15 1.5 
11 Kligman Formula 45 4.5 
12 Mometasone Cream 5 0.5 
13 Cosmetic Multani 15 1.5 
14 Navjeevan Cream 5 0.5 
15 No Marks Cream 20 2 
16 Olay Cream 10 1 
17 Hotel Cream 5 0.5 
18 Ponds White Beauty 35 3.5 
19 Roop Mantra Cream 20 2 
20 Skin Fruit Cream 10 1 
21 Turm Plus (Ayurvedic) 5 0.5 
22 Vico Turmeric- Diva Ayurvedic 10 1 
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Most common side efect of these de-pigmenting agent was Monomorphic Acne in 79% of patients 
followed by pustular acne(8%), nodular acne(4%), rosacea(4%), nodulocystic acne (3%) and perioral 
dermatitis(2%). Source of advice for initiation of steroid application was mostly from friend (39%) 
followed by family member (13.5%), self-application (12%) influenced by advertisements, chemist 
(11.5%), general practitioner (9.5%), neighbor (4.5%), compounder(1.5%), parlor(2%), diploma in 
dermatology(1.5%), dermatologist(0.5%). (Figure 1 & 2) 
   Figure 1      Figure 2  
 
Females (51%) were more commonly affected as compared to males (49%). Urban patients were 
mostly affected (74%) as compared to rural(26%). unmarried(76%) is mostly affected as compared to 
married(24%).out of 11 to 40 years of age group 11 to 20 years age group (58%) mainly affected 
followed by 21 to 30 years age group(36%). only 5 %  were illiterate. 95 % were educated and 
qualification above 10
th
 class. (Figure 3 &4)  
  Figure 3      Figure 4
 
IV. DISCUSSION 
Topical steroids were first used in dermatology by Sulzberger and Witten in 1952 when they published 
an article on the effect of topically applied compound F in selected dermatoses.
1
 Subsequently, various 
other topical steroids were introduced with varying potencies and formulations. The availability of 
these drugs revolutionized the treatment of various steroid responsive dermatoses. Topical steroids have 
greatly contributed to the dermatologist's ability to effectively treat several difficult dermatoses.
2
 They 
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were hailed as a panacea for all ills by physicians and patients and gained rapid popularity.
3
 Topical 
steroids are one of the most commonly used drugs by dermatologists worldwide.
4,5 
However, the 
dramatic symptomatic relief from these medications led to misuse and abuse of these drugs by both 
non-dermatologists and patients. Topical steroids were used by many patients as fairness or cosmetic 
creams.
6,7
  
The rampant misuse and abuse of these medicines led to the development of various side effects, both 
cutaneous and systemic.
7,8,9  
Various studies have tried to highlight the menace caused by the use of 
topical steroids.
10,11
 A multicentric study by Saraswat et al. has also been done to highlight the topical 
steroid abuse on the face.
10 
This study also highlighted the misuse of topical steroid and unlabed steroid 
containing cosmetics, due to day by day alarming increasing use of these formulations resulting in 
shooting prevalence and  incidence of  acne over face.  
In  Jha and Saraswat study females were 83% and males were 17% affected
12,13
 whereas in this study 
although females were more than males but it was 51% females and 49% males. In Kajal study
14
 age 
group 11 to 20 years was most affected similar observations were made by this study.  Predominantly 
21 to 30 years age group was found to be affected in Saraswat and Jha study
12,13
 whereas 31 to 40 years 
age group was  predominantly affected in Rohini study
11
 but in this study predominant age group of 11-
20 years (58%) followed by 21 to 30 years age group(36%). 
In Rohini study Betamethasone or Clobetasol ointments were used in 37.5% of cases.
11
 In Jha study 
Betamethasone Valerate alone were dispensed in 92/410 patients (22.4%) as fairness cream/antiacne 
cream, Kligman formula in 43/410 patients (10.4%).
12
 Observations of this study were well in 
resonance with others i.e. Betamethasone (32.5%), Clobetasol (25%) and Kligman (45;4.5%) were 
mainly used by patient.  
In study conducted by Rohini the use of corticosteroids was attributed at the advice of pharmacists 
(34.5%) followed by friends and relatives (30.5%), cosmetologists (11.0%), non-dermatology 
physicians (15.0%) and by dermatologists in only in 9%.
11
. Jha et all reported that in 8.5% were 
recommended TC by a beautician (beauty parlors), in 20% by their friends, family members, or 
neighbors, in 18.2% by a non-dermatologist practitioner and only in 10.2% by a dermatologist.
12
  
Almost similar was observed in present study that these agents were used as per advice of pharmacists 
in 11.5%, compounder in 1.5% friends and relatives in 57%, parlour in 2.0%, non-dermatology 
physicians in  9.5% and dermatologists only in 2%.  
In Kajal study
14
 45% of the patients belonged to urban areas whereas 28% were from suburban and 
27% from rural areas. Present study also observed almost similar i.e. 74% were urban and 26% were 
rural. And unmarried (76%) were mostly affected as compared to married (24%) in this study may be 
because of more conscious for fairness and beauty so they are deliberately using various cream.  
In this study steroid induced acne observed in which Monomorphic acne (79%) was most commonly 
diagnosed followed by pustular acne(8%), nodular acne(4%), rosacea(4%), nodulocystic acne (3%) and 
perioral dermatitis(2%) In Jha study Steroid-induced acne was seen in 176 patients (42.9%), perioral 
dermatitis in 21 patients (5.1%), and steroid induced rosacea in 28 patients (6.8%).
12
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V. CONCLUSION 
This present study concludes that 90.10% patients of Acne were using steroid and unlabeled steroid 
containing cosmetics and mostly were using on advice of their friends. Betamethasone was most 
commonly used agent followed by Clobetasol, unlabeled steroid containing cosmetics, Aloe Vera gel 
etc. Monomorphic acne was main side effect diagnosed.  
Study concluded that misuse of topical steroids and unlabeled steroid containing cosmetics causing 
various side effects. It is unethical to sale and use without the prescription of an authorized person. So 
this depigmenting agent should be banned to sell without authorization and without the prescription of 
an authorized person. 
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